McKesson Receives a New Rating from Top Analyst

By Carrie Williams

McKesson (NYSE: MCK) received a Hold rating from Standpoint Research analyst Ronnie Moas today. The company’s shares opened today at $146.74.

According to, Moas is a top 100 analyst with an average return of 5.2% and a 70.2% success rate. Moas covers the Technology sector, focusing on stocks such as Lexmark International, Nuance Communications, and Ultra Clean Holdings.

Currently, the analyst consensus on McKesson is Hold and the average price target is $174.50, representing a 18.9% upside.

In a report issued on October 28, Deutsche Bank also downgraded the stock to Hold with a $153 price target.

McKesson’s market cap is currently $33.33B and has a P/E ratio of 16.70. The company has a book value ratio of 3.5276.

Based on the recent corporate insider activity of 40 insiders, corporate insider sentiment is negative on the stock. Earlier this month, Susan Salka, a Director at MCK bought 1,000 shares for a total of $136,350.

McKesson Corp. is a health services and information technology company, which provides medicines, pharmaceutical and care management products. It operates through the McKesson Distribution Solutions and McKesson Technology Solutions segments. The McKesson Distribution Solutions segment distributes ethical and proprietary drugs, medical-surgical supplies and equipment and health and beauty care products throughout North America. This segment also provides specialty pharmaceutical solutions for biotech and pharmaceutical manufacturers, sells financial, operational and clinical solutions for pharmacies. The McKesson Technology Solutions segment provides software, automation, business services and consulting to hospitals, physician offices, imaging centers and home healthcare. It also provides interactive connectivity services that streamline clinical, financial and administrative communication between patients, providers, payers, pharmacies and financial institutions agencies and payers. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Wilmington, DE.